ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,257, issued on Nov. 4.
"Implantable glucose sensors and methods of glucose measurement configured for minimal sensor surface obstruction" was invented by Paul V. Goode (Temple, Texas), Mark Allan Tapsak (Front Royal, Va.), James Patrick Thrower (Bethesda, Md.) and Peter Koziar Jr. (Lititz, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A device for continuously monitoring glucose levels in a patient includes a lead assembly in electrical communication with an electronics assembly. The electronics assembly is configured to be positioned in the subcutaneous tissue and the lead assembly is configured to be positioned in a vessel of the patient, such...